BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

95.28

+1.14 (1.21%)

Dec 24, 2025, 12:27 PM EST - Market open

Revenue Breakdown

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2016 - 2020
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)	2.26B	2.43B	Log In	Log In	Log In	Upgrade
Other Sales Revenue (Post-FY2023 Reporting)	277.80M	319.00M	Log In	Log In	Log In	Upgrade
Revenue (Other)	613.00M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	3.15B	2.75B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2016 - 2020
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting)	-	-	Log In	Log In	Log In	Upgrade
Other Sales Revenue (Pre-FY2024 Reporting)	-	-	Log In	Log In	Log In	Upgrade
Commercial Revenue	-	-	Log In	Log In	Log In	Upgrade
Research & Development Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	3.15B	2.75B	Log In	Log In	Log In	Upgrade

Updated Nov 3, 2025. Data Source: Fiscal.ai.